{"id":"https://openalex.org/W7154472957","doi":"https://doi.org/10.1080/19420862.2026.2657629","title":"Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis","display_name":"Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis","publication_year":2026,"publication_date":"2026-04-15","ids":{"openalex":"https://openalex.org/W7154472957","doi":"https://doi.org/10.1080/19420862.2026.2657629","pmid":"https://pubmed.ncbi.nlm.nih.gov/41982149","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13085943"},"language":"en","primary_location":{"id":"doi:10.1080/19420862.2026.2657629","doi":"https://doi.org/10.1080/19420862.2026.2657629","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2026.2657629","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1080/19420862.2026.2657629","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014748409","display_name":"Gary P. Sims","orcid":"https://orcid.org/0000-0003-2796-0485","observed_orcids":["https://orcid.org/0000-0003-2796-0485"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Gary P. Sims","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133725243","display_name":"Lacie Scaletta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lacie Scaletta","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133725704","display_name":"John Andrews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Andrews","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110640429","display_name":"Dorothy A. Sims","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dorothy A. Sims","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102680014","display_name":"Martin Strain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin Strain","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anna Sigurdardottir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna Sigurdardottir","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076806999","display_name":"Teneema Kuriakose","orcid":"https://orcid.org/0000-0003-4032-1290","observed_orcids":["https://orcid.org/0000-0003-4032-1290"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Teneema Kuriakose","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005908111","display_name":"Elizabeth England","orcid":"https://orcid.org/0000-0001-9581-0046","observed_orcids":["https://orcid.org/0000-0001-9581-0046","https://orcid.org/0000-0002-6432-8123"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth England","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058985246","display_name":"Lichchavi Dhananjaya Rajasinghe","orcid":"https://orcid.org/0000-0002-5136-7422","observed_orcids":["https://orcid.org/0000-0002-5136-7422"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lichchavi Rajasinghe","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102100801","display_name":"Fanyi Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Fanyi Jiang","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ximing Xiong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ximing Xiong","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052784431","display_name":"Frances Neal","orcid":"https://orcid.org/0009-0009-5674-9209","observed_orcids":["https://orcid.org/0009-0009-5674-9209"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Frances Neal","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":"https://orcid.org/0009-0009-5674-9209","affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033942872","display_name":"Lisa Vinall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lisa Vinall","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133636622","display_name":"Philip Newton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Philip Newton","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032950010","display_name":"Elin Boger","orcid":"https://orcid.org/0000-0002-8913-3779","observed_orcids":["https://orcid.org/0000-0002-8913-3779"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elin Boger","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133726979","display_name":"Chong Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chong Kim","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087603780","display_name":"Helena Dahlb\u00e4ck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Helena Dahlb\u00e4ck","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010876723","display_name":"Susanne Prothon","orcid":"https://orcid.org/0000-0002-3084-1658","observed_orcids":["https://orcid.org/0000-0002-3084-1658"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Susanne Prothon","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083850527","display_name":"Jacob Leander","orcid":"https://orcid.org/0000-0002-7411-2967","observed_orcids":["https://orcid.org/0000-0002-7411-2967"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jacob Leander","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057205976","display_name":"Erika Darrah","orcid":"https://orcid.org/0000-0003-1119-0279","observed_orcids":["https://orcid.org/0000-0003-1119-0279"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Erika Darrah","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040095905","display_name":"Mia Collins","orcid":"https://orcid.org/0000-0001-6792-2059","observed_orcids":["https://orcid.org/0000-0001-6792-2059"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mia Collins","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108466464","display_name":"Garry J. Douglas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Garry Douglas","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041870860","display_name":"Nicholas White","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicholas White","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133654575","display_name":"Katie Day","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Katie Day","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082220264","display_name":"Katherine A. Vousden","orcid":"https://orcid.org/0000-0002-0309-5960","observed_orcids":["https://orcid.org/0000-0002-0309-5960"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Katherine A. Vousden","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047036103","display_name":"C Chaillan Huntington","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Catherine E. Huntington","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109456794","display_name":"David Close","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Close","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5014748409"],"corresponding_institution_ids":["https://openalex.org/I105036370"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":21.9682,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.99591596,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"18","issue":"1","first_page":"2657629","last_page":"2657629"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.7699999809265137},{"id":"https://openalex.org/keywords/peptidylarginine-deiminase","display_name":"peptidylarginine deiminase","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pad2","display_name":"PAD2","score":0.8500000238418579},{"id":"https://openalex.org/keywords/pad4","display_name":"PAD4","score":1.0},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9570000171661377},{"id":"https://openalex.org/keywords/protein-citrullination","display_name":"citrullination","score":0.7979999780654907},{"id":"https://openalex.org/keywords/histone-h3-citrullination","display_name":"histone H3 citrullination","score":0.8399999737739563},{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":0.8379999995231628},{"id":"https://openalex.org/keywords/monocytes","display_name":"monocytes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/autoimmunity","display_name":"autoimmunity","score":0.578000009059906},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6700000166893005},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9369999766349792},{"id":"https://openalex.org/keywords/non-human-primate-toxicity","display_name":"non-human primate toxicity","score":0.6930000185966492},{"id":"https://openalex.org/keywords/antibody-internalization","display_name":"antibody internalization","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6722000241279602},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.6171000003814697},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.5884000062942505},{"id":"https://openalex.org/C48632299","wikidata":"https://www.wikidata.org/wiki/Q68581","display_name":"Citrullination","level":5,"score":0.5723000168800354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5264999866485596},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5264000296592712},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.4975999891757965},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4724000096321106},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4713999927043915},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.46230000257492065},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.42719998955726624},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4050999879837036},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3968000113964081},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.39559999108314514},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.38190001249313354},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3718000054359436},{"id":"https://openalex.org/C2777652487","wikidata":"https://www.wikidata.org/wiki/Q575064","display_name":"Synovial membrane","level":3,"score":0.34049999713897705},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.3061000108718872},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.302700012922287},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.2985000014305115},{"id":"https://openalex.org/C2780545709","wikidata":"https://www.wikidata.org/wiki/Q21130552","display_name":"HMGB1","level":3,"score":0.2953000068664551},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.25999999046325684},{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.2531000077724457}],"mesh":[{"descriptor_ui":"D000076342","descriptor_name":"Protein-Arginine Deiminases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000076342","descriptor_name":"Protein-Arginine Deiminases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000080002","descriptor_name":"Protein-Arginine Deiminase Type 4","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000080002","descriptor_name":"Protein-Arginine Deiminase Type 4","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/19420862.2026.2657629","doi":"https://doi.org/10.1080/19420862.2026.2657629","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2026.2657629","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13085943","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13085943/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13085943/pdf/KMAB_18_2657629.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmid:41982149","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41982149","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2b79dfdf9dc346f1b72ec3c3f3f68a4e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2b79dfdf9dc346f1b72ec3c3f3f68a4e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"mAbs, Vol 18, Iss 1 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/19420862.2026.2657629","doi":"https://doi.org/10.1080/19420862.2026.2657629","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2026.2657629","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7154472957.pdf","grobid_xml":"https://content.openalex.org/works/W7154472957.grobid-xml"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W1073804048","https://openalex.org/W1534043095","https://openalex.org/W1967211753","https://openalex.org/W1985820548","https://openalex.org/W1996045402","https://openalex.org/W1997640981","https://openalex.org/W2015865604","https://openalex.org/W2024988150","https://openalex.org/W2038970774","https://openalex.org/W2054686030","https://openalex.org/W2060793088","https://openalex.org/W2072460496","https://openalex.org/W2082888832","https://openalex.org/W2092363477","https://openalex.org/W2093413416","https://openalex.org/W2093560295","https://openalex.org/W2097957649","https://openalex.org/W2100276770","https://openalex.org/W2102079012","https://openalex.org/W2125930376","https://openalex.org/W2142396487","https://openalex.org/W2146707828","https://openalex.org/W2157558787","https://openalex.org/W2163652380","https://openalex.org/W2164300339","https://openalex.org/W2167212772","https://openalex.org/W2169489997","https://openalex.org/W2257056231","https://openalex.org/W2274704536","https://openalex.org/W2321812211","https://openalex.org/W2402220401","https://openalex.org/W2533494998","https://openalex.org/W2571209437","https://openalex.org/W2582017063","https://openalex.org/W2759451658","https://openalex.org/W2766888414","https://openalex.org/W2791691174","https://openalex.org/W2808487458","https://openalex.org/W2889362907","https://openalex.org/W2895572026","https://openalex.org/W2901827656","https://openalex.org/W2939132389","https://openalex.org/W2943164804","https://openalex.org/W3000238803","https://openalex.org/W3019144294","https://openalex.org/W3035641909","https://openalex.org/W3036872165","https://openalex.org/W3162697545","https://openalex.org/W4211054359","https://openalex.org/W4212969233","https://openalex.org/W4282931474","https://openalex.org/W4295873701","https://openalex.org/W4319593293","https://openalex.org/W4385954560","https://openalex.org/W4391575552","https://openalex.org/W4394874512","https://openalex.org/W4400177444","https://openalex.org/W4401321790","https://openalex.org/W4401629856","https://openalex.org/W4404525136","https://openalex.org/W4409112844","https://openalex.org/W4412707901"],"related_works":["https://openalex.org/W4399482206","https://openalex.org/W4379650108","https://openalex.org/W2315651513","https://openalex.org/W3019144294","https://openalex.org/W2093413416","https://openalex.org/W2774231884","https://openalex.org/W1981788367","https://openalex.org/W2167212772","https://openalex.org/W4409112844","https://openalex.org/W4313430170"],"abstract_inverted_index":{"Anti-citrullinated":[0],"protein":[1],"autoantibodies":[2],"promote":[3],"inflammation":[4],"and":[5,9,39,43,62,85,92,116,126,143,151,187,202,205,223,227],"joint":[6],"tissue":[7,63],"injury":[8,64],"define":[10],"a":[11,72,180,189,198,203,214,237],"poor":[12],"prognostic":[13],"group":[14],"of":[15,50,56,105,110,113,147,164,173,184,192,208,234],"patients":[16,106],"with":[17,107,197],"rheumatoid":[18],"arthritis":[19],"(RA).":[20],"Citrullinated":[21],"autoantigens":[22,58],"that":[23,59],"drive":[24,60],"this":[25],"autoimmune":[26],"response":[27],"are":[28,36],"generated":[29],"by":[30,41,243],"peptidylarginine":[31],"deiminase":[32],"(PAD)":[33],"enzymes,":[34],"which":[35,80],"predominately":[37],"expressed":[38,129],"released":[40],"neutrophils":[42,150],"monocytes.":[44],"Accordingly,":[45],"blocking":[46],"the":[47,54,103,111,140,162,231],"enzymatic":[48],"activity":[49,87,101,119],"PADs":[51,128],"to":[52,149],"curb":[53],"generation":[55],"citrullinated":[57],"autoimmunity":[61],"may":[65],"provide":[66],"therapeutic":[67,239],"benefit.":[68],"Herein,":[69],"we":[70],"developed":[71],"high":[73],"affinity,":[74],"bispecific,":[75],"anti-PAD2/4,":[76],"effector-null":[77],"antibody,":[78],"AZD1163,":[79],"potently":[81],"inhibits":[82],"recombinant":[83],"PAD2":[84],"PAD4":[86],"in":[88,102,120,221,224],"both":[89],"histone":[90],"H3":[91],"fibrinogen":[93],"citrullination":[94],"assays.":[95],"AZD1163":[96,123,148,193,212,235],"inhibited":[97],"all":[98],"endogenous":[99,209],"PAD":[100,118,210],"serum":[104],"RA":[108,242],"irrespective":[109],"presence":[112],"anti-PAD4":[114],"autoantibodies,":[115],"neutralized":[117],"synovial":[121],"fluid.":[122],"also":[124],"bound":[125],"internalized":[127],"on":[130],"cell":[131],"membranes":[132],"into":[133],"low":[134],"pH":[135],"endosomes":[136],"for":[137,241],"degradation,":[138],"reducing":[139,244],"surface":[141],"expression":[142],"catalytic":[144],"potential.":[145],"Binding":[146],"monocytes":[152],"did":[153],"not":[154],"trigger":[155],"complement-dependent":[156],"cytotoxicity,":[157,160],"antibody-dependent":[158],"cellular":[159],"or":[161,167,177],"production":[163,172],"proinflammatory":[165],"cytokines,":[166],"otherwise":[168],"impact":[169],"neutrophil":[170],"phagocytosis,":[171],"reactive":[174],"oxygen":[175],"species,":[176],"NETosis.":[178],"In":[179],"non-human":[181],"primate":[182],"study":[183],"pharmacokinetics":[185],"(PK)":[186],"pharmacodynamics,":[188],"single":[190],"dose":[191],"exhibited":[194],"PK":[195],"consistent":[196],"half-life":[199],"extended":[200],"antibody":[201],"rapid":[204],"durable":[206],"suppression":[207],"activity.":[211],"has":[213],"favorable":[215],"preclinical":[216],"safety":[217,228],"profile.":[218],"Collectively,":[219],"these":[220],"vitro":[222],"vivo":[225],"pharmacology":[226],"data":[229],"support":[230],"clinical":[232],"development":[233],"as":[236],"novel":[238],"strategy":[240],"autoantigen":[245],"load.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-04-16T00:00:00"}